(-)-demecolcine increases expression ISO RGD:736636 6480464 Demecolcine results in increased expression of GLS mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736636 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLS mRNA CTD PMID:22079256 (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased activity of GLS protein] CTD PMID:32061141 1,1-dichloroethene decreases expression ISO RGD:10659 6480464 vinylidene chloride results in decreased expression of GLS mRNA CTD PMID:26682919 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of GLS protein CTD PMID:17337753 1,2-dichloroethane affects expression ISO RGD:10659 6480464 ethylene dichloride affects the expression of GLS mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:10659 6480464 1, 2-Dimethylhydrazine results in decreased expression of GLS mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10659 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GLS mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GLS mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of GLS mRNA CTD PMID:20170705 , PMID:26865667 17beta-estradiol affects expression ISO RGD:736636 6480464 Estradiol affects the expression of GLS mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:736636 6480464 Estradiol results in increased expression of GLS mRNA, Estradiol results in increased expression of GLS protein CTD PMID:27514991 , PMID:31614463 17beta-estradiol multiple interactions ISO RGD:736636 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of GLS protein], MYC protein promotes the reaction [Estradiol results in increased expression of GLS protein] CTD PMID:27514991 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10659 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10659 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736636 6480464 Tetrachlorodibenzodioxin results in increased expression of GLS mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GLS mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10659 6480464 Tetrachlorodibenzodioxin results in increased expression of GLS mRNA CTD PMID:19770486 , PMID:27562557 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GLS mRNA, alpha-Chlorohydrin results in increased expression of GLS protein CTD PMID:28522335 , PMID:34915118 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GLS mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases methylation ISO RGD:736636 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of GLS gene CTD PMID:31601247 7,12-dimethyltetraphene increases expression ISO RGD:736636 6480464 9 more ... CTD PMID:21527772 acetamide increases expression EXP 6480464 acetamide results in increased expression of GLS mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:736636 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GLS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GLS mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GLS mRNA CTD PMID:15749267 aflatoxin B1 increases expression ISO RGD:10659 6480464 Aflatoxin B1 results in increased expression of GLS mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:736636 6480464 Aflatoxin B1 results in increased expression of GLS mRNA CTD PMID:21641981 all-trans-retinoic acid increases expression ISO RGD:736636 6480464 Tretinoin results in increased expression of GLS mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO RGD:736636 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GLS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GLS mRNA CTD PMID:32699268 amitraz multiple interactions EXP 6480464 [methylhistaprodifen co-treated with Idazoxan] inhibits the reaction [amitraz results in increased expression of GLS mRNA], methylhistaprodifen inhibits the reaction [amitraz results in increased expression of GLS mRNA] CTD PMID:26141220 amitraz increases expression EXP 6480464 amitraz results in increased expression of GLS mRNA CTD PMID:26141220 ammonia multiple interactions ISO RGD:10659 6480464 [Hydrochloric Acid results in decreased expression of GLS protein] which results in increased secretion of Ammonia, [RHBG protein mutant form results in decreased expression of GLS protein] which results in increased secretion of Ammonia CTD PMID:20719974 ammonia affects secretion ISO RGD:10659 6480464 GLS protein affects the secretion of Ammonia CTD PMID:20719974 ammonium chloride increases expression ISO RGD:10659 6480464 Ammonium Chloride results in increased expression of GLS protein CTD PMID:18287403 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GLS mRNA CTD PMID:16483693 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GLS mRNA CTD PMID:25607892 antirheumatic drug decreases expression ISO RGD:736636 6480464 Antirheumatic Agents results in decreased expression of GLS mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:736636 6480464 aristolochic acid I results in increased expression of GLS protein CTD PMID:33212167 aristolochic acid A decreases expression ISO RGD:736636 6480464 aristolochic acid I results in decreased expression of GLS mRNA CTD PMID:33212167 arsane decreases activity ISO RGD:736636 6480464 Arsenic results in decreased activity of GLS protein CTD PMID:19428935 arsenic atom decreases activity ISO RGD:736636 6480464 Arsenic results in decreased activity of GLS protein CTD PMID:19428935 arsenous acid decreases response to substance ISO RGD:736636 6480464 GLS protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24276018 arsenous acid increases expression ISO RGD:736636 6480464 Arsenic Trioxide results in increased expression of GLS mRNA CTD PMID:20458559 benzatropine multiple interactions ISO RGD:736636 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of GLS protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:10659 6480464 Benzo(a)pyrene results in decreased expression of GLS mRNA CTD PMID:19770486 , PMID:23735875 benzo[a]pyrene decreases methylation ISO RGD:10659 6480464 Benzo(a)pyrene results in decreased methylation of GLS intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:736636 6480464 Benzo(a)pyrene results in increased expression of GLS mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:736636 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO RGD:736636 6480464 7 more ... CTD PMID:26238291 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 bisphenol A affects expression ISO RGD:736636 6480464 bisphenol A affects the expression of GLS mRNA CTD PMID:20170705 bisphenol A decreases methylation ISO RGD:736636 6480464 bisphenol A results in decreased methylation of GLS gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:736636 6480464 bisphenol A results in increased expression of GLS mRNA CTD PMID:33670352 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GLS mRNA CTD PMID:30816183 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GLS mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GLS mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GLS mRNA CTD PMID:25607892 butanal increases expression ISO RGD:736636 6480464 butyraldehyde results in increased expression of GLS mRNA CTD PMID:26079696 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GLS mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GLS mRNA CTD PMID:25607892 cadmium atom multiple interactions ISO RGD:736636 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GLS mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GLS mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:736636 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GLS mRNA CTD PMID:35301059 calcitriol decreases expression ISO RGD:736636 6480464 Calcitriol results in decreased expression of GLS mRNA CTD PMID:16002434 carbon nanotube affects expression ISO RGD:10659 6480464 Nanotubes, Carbon affects the expression of GLS mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:10659 6480464 Nanotubes, Carbon analog results in decreased expression of GLS mRNA CTD PMID:25554681 chlorpyrifos increases activity ISO RGD:10659 6480464 Chlorpyrifos results in increased activity of GLS protein CTD PMID:29665406 choline multiple interactions ISO RGD:10659 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLS mRNA CTD PMID:20938992 cis-caffeic acid increases expression ISO RGD:736636 6480464 caffeic acid results in increased expression of GLS protein CTD PMID:28576465 cisplatin increases expression ISO RGD:736636 6480464 Cisplatin results in increased expression of GLS mRNA CTD PMID:19561079 cisplatin multiple interactions ISO RGD:736636 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of GLS mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:736636 6480464 Cisplatin results in decreased expression of GLS mRNA CTD PMID:27392435 copper atom increases expression EXP 6480464 Copper results in increased expression of GLS mRNA CTD PMID:22465980 copper(0) increases expression EXP 6480464 Copper results in increased expression of GLS mRNA CTD PMID:22465980 copper(II) sulfate increases expression ISO RGD:736636 6480464 Copper Sulfate results in increased expression of GLS mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:736636 6480464 Coumestrol results in decreased expression of GLS mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:736636 6480464 Asbestos, Crocidolite results in increased expression of GLS mRNA CTD PMID:25351596 crocidolite asbestos decreases expression ISO RGD:10659 6480464 Asbestos, Crocidolite results in decreased expression of GLS mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GLS mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO RGD:736636 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of GLS protein CTD PMID:34122009 cyclophosphamide increases expression ISO RGD:736636 6480464 Cyclophosphamide results in increased expression of GLS mRNA CTD PMID:21527772 cyclophosphamide affects response to substance ISO RGD:736636 6480464 GLS protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 cyclosporin A decreases expression ISO RGD:736636 6480464 Cyclosporine results in decreased expression of GLS mRNA CTD PMID:22147139 more ... cytarabine decreases expression ISO RGD:736636 6480464 Cytarabine results in decreased expression of GLS mRNA CTD PMID:21198554 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 dextran sulfate decreases expression ISO RGD:10659 6480464 Dextran Sulfate results in decreased expression of GLS protein CTD PMID:32272095 dextran sulfate multiple interactions ISO RGD:10659 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GLS protein] CTD PMID:32272095 diarsenic trioxide increases expression ISO RGD:736636 6480464 Arsenic Trioxide results in increased expression of GLS mRNA CTD PMID:20458559 diarsenic trioxide decreases response to substance ISO RGD:736636 6480464 GLS protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24276018 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GLS mRNA CTD PMID:29108742 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 diuron decreases expression EXP 6480464 Diuron results in decreased expression of GLS mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GLS mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GLS mRNA CTD PMID:25607892 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 fenamidone decreases expression ISO RGD:10659 6480464 fenamidone results in decreased expression of GLS mRNA CTD PMID:27029645 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of GLS mRNA CTD PMID:30307764 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of GLS mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:10659 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:10659 6480464 Folic Acid results in decreased expression of GLS mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:736636 6480464 Formaldehyde results in increased expression of GLS mRNA CTD PMID:20655997 , PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of GLS mRNA CTD PMID:27387713 furan decreases methylation EXP 6480464 furan results in decreased methylation of GLS gene CTD PMID:27387713 geldanamycin increases expression ISO RGD:736636 6480464 geldanamycin results in increased expression of GLS mRNA CTD PMID:26705709 genistein decreases expression ISO RGD:736636 6480464 Genistein results in decreased expression of GLS mRNA CTD PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GLS mRNA CTD PMID:22061828 Heliotrine increases expression ISO RGD:736636 6480464 heliotrine results in increased expression of GLS mRNA CTD PMID:26100227 hexadecanoic acid decreases oxidation ISO RGD:736636 6480464 GLS protein results in decreased oxidation of Palmitic Acid CTD PMID:31040181 hydrogen chloride multiple interactions ISO RGD:10659 6480464 [Hydrochloric Acid results in decreased expression of GLS protein] which results in increased secretion of Ammonia CTD PMID:20719974 hydrogen chloride increases expression ISO RGD:10659 6480464 Hydrochloric Acid results in increased expression of GLS mRNA, Hydrochloric Acid results in increased expression of GLS protein CTD PMID:20719974 , PMID:29618784 hydrogen peroxide affects expression ISO RGD:736636 6480464 Hydrogen Peroxide affects the expression of GLS mRNA CTD PMID:20044591 hydrogen peroxide decreases response to substance ISO RGD:736636 6480464 GLS protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:24276018 hydrogen peroxide multiple interactions ISO RGD:736636 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of GLS protein CTD PMID:18951874 idazoxan multiple interactions EXP 6480464 [methylhistaprodifen co-treated with Idazoxan] inhibits the reaction [amitraz results in increased expression of GLS mRNA] CTD PMID:26141220 indometacin decreases expression ISO RGD:736636 6480464 Indomethacin results in decreased expression of GLS mRNA CTD PMID:16984733 ivermectin decreases expression ISO RGD:736636 6480464 Ivermectin results in decreased expression of GLS protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:736636 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of GLS mRNA CTD PMID:17639512 L-methionine multiple interactions ISO RGD:10659 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLS mRNA CTD PMID:20938992 lactacystin multiple interactions ISO RGD:736636 6480464 lactacystin inhibits the reaction [diphenylarsinic acid results in increased degradation of GLS protein alternative form] CTD PMID:22493432 lead(0) decreases activity EXP 6480464 Lead results in decreased activity of GLS protein CTD PMID:15149801 lead(0) affects expression ISO RGD:736636 6480464 Lead affects the expression of GLS mRNA CTD PMID:28903495 lead(2+) decreases activity EXP 6480464 Lead results in decreased activity of GLS protein CTD PMID:15149801 lead(2+) affects expression ISO RGD:736636 6480464 Lead affects the expression of GLS mRNA CTD PMID:28903495 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased activity of GLS protein] CTD PMID:32061141 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA] CTD PMID:19149911 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA] CTD PMID:19149911 menadione affects expression ISO RGD:736636 6480464 Vitamin K 3 affects the expression of GLS mRNA CTD PMID:20044591 mercury dibromide increases expression ISO RGD:736636 6480464 mercuric bromide results in increased expression of GLS mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA CTD PMID:27188386 metformin decreases expression ISO RGD:736636 6480464 Metformin results in decreased expression of GLS protein CTD PMID:28576465 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA], Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA] CTD PMID:19149911 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of GLS mRNA CTD PMID:19149911 methotrexate decreases expression ISO RGD:736636 6480464 Methotrexate results in decreased expression of GLS mRNA CTD PMID:24449571 methyl methanesulfonate increases expression ISO RGD:736636 6480464 Methyl Methanesulfonate results in increased expression of GLS mRNA CTD PMID:21527772 methyl methanesulfonate decreases expression ISO RGD:736636 6480464 Methyl Methanesulfonate results in decreased expression of GLS mRNA CTD PMID:23649840 methylmercury chloride increases activity EXP 6480464 methylmercuric chloride results in increased activity of GLS protein CTD PMID:22223486 , PMID:32061141 methylmercury chloride increases expression ISO RGD:736636 6480464 methylmercuric chloride results in increased expression of GLS mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:736636 6480464 methylmercuric chloride results in decreased expression of GLS mRNA CTD PMID:23179753 methylmercury chloride multiple interactions EXP 6480464 Polyphenols inhibits the reaction [methylmercuric chloride results in increased activity of GLS protein], Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased activity of GLS protein] CTD PMID:22223486 , PMID:32061141 motexafin gadolinium decreases expression ISO RGD:736636 6480464 motexafin gadolinium results in decreased expression of GLS mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions ISO RGD:736636 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GLS mRNA CTD PMID:16357179 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:736636 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [diphenylarsinic acid results in increased degradation of GLS protein alternative form] CTD PMID:22493432 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GLS mRNA CTD PMID:20360939 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of GLS mRNA CTD PMID:25380136 naphthalenes decreases expression EXP 6480464 Naphthalenes results in decreased expression of GLS protein CTD PMID:17337753 nickel atom increases expression ISO RGD:736636 6480464 Nickel results in increased expression of GLS mRNA CTD PMID:24768652 , PMID:25583101 O-palmitoylcarnitine increases chemical synthesis ISO RGD:736636 6480464 GLS protein results in increased chemical synthesis of Palmitoylcarnitine CTD PMID:31040181 ochratoxin A decreases expression ISO RGD:736636 6480464 ochratoxin A results in decreased expression of GLS mRNA CTD PMID:32905824 ozone multiple interactions ISO RGD:736636 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GLS mRNA more ... CTD PMID:32699268 p-chloromercuribenzoic acid increases expression ISO RGD:736636 6480464 p-Chloromercuribenzoic Acid results in increased expression of GLS mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA CTD PMID:27188386 palbociclib increases expression ISO RGD:736636 6480464 palbociclib results in increased expression of GLS mRNA CTD PMID:28620137 panobinostat multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:736636 6480464 panobinostat results in increased expression of GLS mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:10659 6480464 Acetaminophen affects the expression of GLS mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:736636 6480464 Acetaminophen results in increased expression of GLS mRNA CTD PMID:21420995 more ... paracetamol affects expression ISO RGD:736636 6480464 Acetaminophen affects the expression of GLS mRNA CTD PMID:25458485 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GLS mRNA CTD PMID:25607892 paraquat decreases activity EXP 6480464 Paraquat results in decreased activity of GLS protein CTD PMID:28916328 PCB138 multiple interactions ISO RGD:10659 6480464 [2 more ... CTD PMID:25510870 perfluorooctanoic acid increases expression ISO RGD:736636 6480464 perfluorooctanoic acid results in increased expression of GLS protein CTD PMID:26879310 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GLS mRNA CTD PMID:20360939 phenylarsonic acid decreases expression ISO RGD:736636 6480464 benzenearsonic acid results in decreased expression of GLS protein CTD PMID:19428935 phenylarsonic acid decreases activity ISO RGD:736636 6480464 benzenearsonic acid results in decreased activity of GLS protein CTD PMID:19428935 phenylmercury acetate increases expression ISO RGD:736636 6480464 Phenylmercuric Acetate results in increased expression of GLS mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:736636 6480464 potassium chromate(VI) results in decreased expression of GLS mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:736636 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLS mRNA CTD PMID:22079256 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 quartz affects expression ISO RGD:10659 6480464 Quartz affects the expression of GLS protein CTD PMID:36053221 quartz multiple interactions ISO RGD:10659 6480464 CAV1 protein modified form inhibits the reaction [Quartz results in increased expression of GLS protein] CTD PMID:36053221 quercetin multiple interactions ISO RGD:736636 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of GLS mRNA CTD PMID:17639512 quercetin increases expression ISO RGD:736636 6480464 Quercetin results in increased expression of GLS mRNA CTD PMID:21632981 rimonabant multiple interactions ISO RGD:10659 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of GLS mRNA] CTD PMID:19030233 sarin decreases expression ISO RGD:736636 6480464 Sarin results in decreased expression of GLS mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine increases expression ISO RGD:736636 6480464 senecionine results in increased expression of GLS mRNA CTD PMID:26100227 Senkirkine increases expression ISO RGD:736636 6480464 senkirkine results in increased expression of GLS mRNA CTD PMID:26100227 silicon dioxide increases expression ISO RGD:736636 6480464 Silicon Dioxide results in increased expression of GLS mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:736636 6480464 Silver results in increased expression of GLS mRNA CTD PMID:26551752 silver atom affects expression ISO RGD:10659 6480464 Silver affects the expression of GLS mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:736636 6480464 Silver results in increased expression of GLS mRNA CTD PMID:26551752 silver(0) affects expression ISO RGD:10659 6480464 Silver affects the expression of GLS mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:10659 6480464 sodium arsenate results in increased expression of GLS mRNA CTD PMID:30953684 sunitinib decreases expression ISO RGD:736636 6480464 Sunitinib results in decreased expression of GLS mRNA CTD PMID:31533062 tanespimycin multiple interactions ISO RGD:736636 6480464 [tanespimycin co-treated with VER 155008] results in decreased expression of GLS protein CTD PMID:31370342 temozolomide decreases expression ISO RGD:736636 6480464 Temozolomide results in decreased expression of GLS mRNA CTD PMID:31758290 tetrachloromethane decreases expression ISO RGD:10659 6480464 Carbon Tetrachloride results in decreased expression of GLS mRNA CTD PMID:26639393 thapsigargin increases expression ISO RGD:736636 6480464 Thapsigargin results in increased expression of GLS mRNA CTD PMID:22378314 , PMID:29453283 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of GLS protein CTD PMID:35544339 theophylline multiple interactions ISO RGD:736636 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of GLS protein CTD PMID:18951874 thimerosal increases expression ISO RGD:736636 6480464 Thimerosal results in increased expression of GLS mRNA CTD PMID:27188386 titanium dioxide increases activity ISO RGD:10659 6480464 titanium dioxide results in increased activity of GLS protein CTD PMID:25411160 toluene increases expression EXP 6480464 Toluene results in increased expression of GLS mRNA CTD PMID:22967744 trans-caffeic acid increases expression ISO RGD:736636 6480464 caffeic acid results in increased expression of GLS protein CTD PMID:28576465 trichostatin A increases expression ISO RGD:736636 6480464 trichostatin A results in increased expression of GLS mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:736636 6480464 trichostatin A affects the expression of GLS mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA CTD PMID:27188386 Triptolide increases expression ISO RGD:10659 6480464 triptolide results in increased expression of GLS mRNA CTD PMID:32835833 troglitazone increases expression ISO RGD:736636 6480464 troglitazone results in increased expression of GLS mRNA CTD PMID:19140230 tungsten increases expression ISO RGD:10659 6480464 Tungsten results in increased expression of GLS mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:736636 6480464 Tunicamycin results in increased expression of GLS mRNA CTD PMID:22378314 undecane decreases expression EXP 6480464 undecane results in decreased expression of GLS protein CTD PMID:17337753 urethane increases expression ISO RGD:736636 6480464 Urethane results in increased expression of GLS mRNA CTD PMID:28818685 valproic acid multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA] CTD PMID:19149911 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of GLS mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:736636 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:736636 6480464 Valproic Acid results in decreased expression of GLS mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736636 6480464 Valproic Acid results in increased expression of GLS mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:736636 6480464 Valproic Acid affects the expression of GLS mRNA CTD PMID:25979313 vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GLS mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:736636 6480464 vorinostat results in increased expression of GLS mRNA CTD PMID:26272509 zinc acetate multiple interactions ISO RGD:736636 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GLS mRNA CTD PMID:16357179 zinc acetate decreases expression ISO RGD:736636 6480464 Zinc Acetate results in decreased expression of GLS mRNA CTD PMID:16357179
